SCHEMBL3743447

SCHEMBL3743447

[NH]C(=O)[N]c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.43
ALDH1A1 P00352 3/20 0.41
HTR3E A5X5Y0 1/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39
SLC22A3 O75751 1/20 0.39
HTR3B O95264 1/20 0.39
PLAU P00749 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
CYP1A2 P05177 1/20 0.38
CES2 O00748 2/20 0.38
CES1 P23141 2/20 0.38
DAO P14920 1/20 0.38
TSHR P16473 1/20 0.38
NAPRT Q6XQN6 1/20 0.38
ALOX15 P16050 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342606 0.78 TRPA1 (0.46) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL4993304 0.78 TRPA1 (0.46) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL4829863 0.76 TRPA1 (0.44) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL10681124 0.75 TDP1 (0.47) ALDH1A1HTR3ESLC22A2SLC22A1SLC22A3
SCHEMBL54470 0.74 HTR3E (0.50) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL834716 0.74 NOS3 (0.48) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL9333342 0.72 HTR3E (0.48) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
SCHEMBL2329631 0.72 CES1 (0.48) TRPA1ALDH1A1CES2CES1DAO
SCHEMBL5681700 0.70 F2 (0.42) TRPA1ALDH1A1HTR3ESLC22A2SLC22A1
Azobenzene SCHEMBL9435350 0.69 ALDH1A1 (0.75) TRPA1ALDH1A1CYP1A2TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-11-04 US claimed
EP-2061449-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES Leo Pharma A/S (DK) 2009-05-27 EP claimed
WO-2008019690-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2008-02-21 WO claimed
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-11-04 US disclosed
EP-2061449-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES Leo Pharma A/S (DK) 2009-05-27 EP disclosed
WO-2008019690-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2008-02-21 WO disclosed
US-4236015-A ANTIINFLAMMATORY AGENTS, IMMUNOSUPPRESSANTS, FUNGICIDES WESTWOOD PHARMACEUTICALS, INC. (US) 1980-11-25 US disclosed
US-4229452-A Treatment of inflammatory disorders with 4-trifluoromethylimidazo[1,2-a]quinoxaline WESTWOOD PHARMACEUTICALS, INC. 1980-10-21 US disclosed
US-4225724-A IMMUNOSUPPRESSANT ACTIVITY WESTWOOD PHARMACEUTICALS, INC. (US) 1980-09-30 US disclosed
US-4200750-A ANTIINFLAMMATORY AGENTS, FUNGICIDES, ANTIBODY INHIBITORS WESTWOOD PHARMACEUTICALS INC. (US) 1980-04-29 US disclosed
US-4198508-A CYCLIZATION OF 1-(2-ACYLAMINOPHENYL)IMIDAZOLES USING PHOSPHORUS OXYCHLORIDE OR POLYPHOSPHORIC ACID WESTWOOD PHARMACEUTICALS INC. (US) 1980-04-15 US disclosed
US-4197403-A ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE, FUNGICIDE WESTWOOD PHARMACEUTICALS INC. (US) 1980-04-08 US disclosed
US-4191766-A 4-(SUBSTITUTED PHENYL OR ANILINO)IMIDAZO(1,2-A)QUINOXALINES WESTWOOD PHARMACEUTICALS, INC. (US) 1980-03-04 US disclosed
US-4191767-A Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines WESTWOOD PHARMACEUTICALS, INC. (US) 1980-03-04 US disclosed
US-4172947-A IMMUNOSUPRESSANTS, AMTIIMFLAMMATORY AGENTS, FUNGICIDES WESTWOOD PHARMACEUTICALS, INC. (US) 1979-10-30 US disclosed
US-4160097-A INTERMEDIATES FOR FUNGICIDAL AND ANTIINFLAMMATORY 4-SUBSTITUTED IMIDAZO(1,2-A)QUINOXALINES WESTWIND PHARMACEUTICALS, INC. (US) 1979-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES C1R, C3AR1, PTH1R TRPA1 3012/4885ALDH1A1 1976/4885HTR3E 2436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.